Cancer biomarkers market in North America was valued at USD 6.88 billion in 2018. North America dominated the global market followed by Europe. Important factors attributed to dominance of North The usa consist of, bigger adoption of Highly developed technologies like next-era sequencing, as well as the escalating range of https://chamfortv997gui2.wikinarration.com/user